Merja Perälä

4.6k citations

62 papers · 3.6k indexed · h-index 34

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Immunology and Allergy 18
- Cell Adhesion Molecules Research 18
Cancer Research 22
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 10

Co-authors: Olli Kallioniemi Suvi‐Katri Leivonen Pekka Kohonen Kristine Kleivi Sahlberg Rami Mäkelä Vidal Fey Anne‐Lise Børresen‐Dale Päivi Östling
Journals: PLoS ONE (6 papers)Cancer Research (4 papers)Molecular Oncology (3 papers)Oncogene (3 papers)Carcinogenesis (2 papers)
Partner nations: Finland United States Norway

In The Last Decade

Merja Perälä

60 papers receiving 3.5k citations

Peers

Countries citing papers authored by Merja Perälä

Since Specialization

Citations

This map shows the geographic impact of Merja Perälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merja Perälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merja Perälä more than expected).

Fields of papers citing papers by Merja Perälä

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merja Perälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merja Perälä. The network helps show where Merja Perälä may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Merja Perälä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Merja Perälä Line = papers co-authored together Merja Perälä links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland Oncotarget ·Wei Zhang, Arndt A. Schmitz, Roosa Kallionpää, Merja Perälä, Niina Pitkänen, 永奎朴, Mariana da Silva Mourão, Korinna Jöhrens, Renate Schulze‐Rath, Bahman Farahmand, Jihong Zong	2024	2
2	ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics Frontiers in Neurology ·Anniina Snellman, Laura L. Ekblad, Katia Sánchez González, Noora Lindgrén, Jouni Tuisku, Merja Perälä, Lila Kallio, Esteban Arias-Méndez, Virva Saunavaara, Jani Saunavaara, Vesa Oikonen, Nicolas Medina, Eliisa Löyttyniemi, Riitta Parkkola, Mira Karrasch, Henrik Zetterberg, Kaj Blennow, Juha O. Rinne	2022	9
3	Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors PLoS ONE ·Espen Enerly, Israel Steinfeld, Kristine Kleivi Sahlberg, Suvi‐Katri Leivonen, Miriam R. R. Aure, Hege G. Russnes, Thalita Lodos da Ressureição, Hilde Johnsen, Roy Navon, A. Lick, Rami Mäkelä, Nataliia Studenets, Merja Perälä, Olli Kallioniemi, Vessela N. Kristensen, Zohar Yakhini, Xavier G. H. Koenig	2013	1
4	High‐throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth Molecular Oncology ·Suvi‐Katri Leivonen, Kristine Kleivi Sahlberg, Rami Mäkelä, Eldri U. Due, Olli Kallioniemi, Anne‐Lise Børresen‐Dale, Merja Perälä	2013	146
5	Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis Oncogene ·Tao He, Saija Haapa-Paananen, Vitaliy O. Kaminskyy, Pekka Kohonen, Vidal Fey, Boris Zhivotovsky, Olli Kallioniemi, Merja Perälä	2013	33
6	Heparin-like Polysaccharides Reduce Osteolytic Bone Destruction and Tumor Growth in a Mouse Model of Breast Cancer Bone Metastasis Molecular Cancer Research ·Sirkku Pollari, J Durant, Khalid S. Mohammad, Jukka P. Rissanen, Jussi M. Halleen, Anni Wärri, Liisa Nissinen, Marjo Pihlavisto, Anne Marjamäki, Merja Perälä, Theresa A. Guise, Olli Kallioniemi, Sanna-Maria Käkönen	2012	40
7	The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells Molecular Oncology ·Kristine Kleivi Sahlberg, Vesa Hongisto, Henrik Edgren, Rami Mäkelä, Kirsi Hellström, Eldri U. Due, Hans Kristian Moen Vollan, Niko Sahlberg, Maija Wolf, Anne‐Lise Børresen‐Dale, Merja Perälä, Olli Kallioniemi	2012	69
8	High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer PLoS ONE ·Paula Vainio, C. Costaguta, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin	2012	55
9	Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells Cancer Research ·Päivi Östling, Suvi‐Katri Leivonen, Anna Aakula, Pekka Kohonen, Rami Mäkelä, Zandra Hagman, Anders Edsjö, Sara Kangaspeska, Henrik Edgren, Daniel Nicorici, Anders Bjartell, Yvonne Ceder, Merja Perälä, Olli Kallioniemi	2011	227
10	HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation Oncogene ·Saija Haapa-Paananen, Santeri Kiviluoto, Marika Waltari, Marjut Puputti, John Patrick Mpindi, Pekka Kohonen, Olli Tynninen, Hannu Haapasalo, Heikki Joensuu, Merja Perälä, Olli Kallioniemi	2011	27
11	Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer American Journal Of Pathology ·Paula Vainio, Santosh Gupta, Kirsi Ketola, Tuomas Mirtti, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Merja Perälä, Frank Smit, Gerald W. Verhaegh, Jack A. Schalken, Kalle Alanen, Olli Kallioniemi, Kristiina Iljin	2011	92
12	Identification of miR-193b Targets in Breast Cancer Cells and Systems Biological Analysis of Their Functional Impact Molecular & Cellular Proteomics ·Suvi‐Katri Leivonen, Anne Rokka, Päivi Östling, Pekka Kohonen, Garry L. Corthals, Olli Kallioniemi, Merja Perälä	2011	67
13	Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration‐resistant prostate cancer The Prostate ·Paula Vainio, Maija Wolf, Henrik Edgren, Tao He, Pekka Kohonen, C. Costaguta, Frank Smit, Gerald W. Verhaegh, Jack A. Schalken, Merja Perälä, Kristiina Iljin, Olli Kallioniemi	2011	24
14	High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth Clinical Cancer Research ·Kristiina Iljin, Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen, Vidal Fey, Roland C. Grafström, Merja Perälä, Olli Kallioniemi	2009	180
15	The role of sequence variations within the genes encoding collagen II, IX and XI in non-syndromic, early-onset osteoarthritis Osteoarthritis and Cartilage ·Eveliina Jakkula, 由美子金子, Ilkka Kiviranta, Jaana Lohiniva, Kazumitsu IMAHARA, Merja Perälä, Matthew L. Warman, Anwar Anwar, Heikki Kröger, H.H.H. Göring, Leena Ala‐Kokko	2005	50
16	Expression of type II and IX collagen isoforms during normal and pathological cartilage and eye development Histochemistry and Cell Biology ·Mikko Savontaus, Tapio Ihanamäki, Merja Perälä, Marjo Metsäranta, Hyo Jin Choi, Eero Vuorio	1998	19
17	Expression of type VI, IX and XI collagen genes and alternative splicing of type II collagen transcripts in fracture callus tissue in mice FEBS Letters ·Arto Hiltunen, Marjo Metsäranta, Merja Perälä, Anna‐Marja Säämänen, Hannu T. Aro, Eero Vuorio	1995	18
18	The Genes Encoding α2(IX) Collagen (COL9A2) Map to Human Chromosome 1p32.3-p33 and Mouse Chromosome 4 Genomics ·Matthew L. Warman, Li XingHai, Merja Perälä, Eero Vuorio, Joan H.M. Knoll, L. Salomon, Richard Mayne, David R. Beier, Bjørn R. Olsen	1994	16
19	Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAs Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Kati Elima, Marjo Metsäranta, Johanna Kallio, Merja Perälä, Iiro Eerola, Silvio Garofalo, Benoît De Crombrugghe, Eero Vuorio	1992	26
20	Differential expression of two α2-adrenergic receptor subtype mRNAs in human tissues Molecular Brain Research ·Merja Perälä, Harri Hirvonen, Hannu Kalimo, Camilla Segerlind, John W. Regan, Karl E.O. Åkerman, Mika Scheinin	1992	33

About Merja Perälä

Merja Perälä is a scholar working on Immunology and Allergy, Cancer Research, Rheumatology, Molecular Biology and Oncology, having authored 62 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (18 papers), MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers), Osteoarthritis Treatment and Mechanisms (10 papers), Connective tissue disorders research (7 papers), Circular RNAs in diseases (7 papers), Prostate Cancer Treatment and Research (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Immunology and Allergy (314 citations), Rheumatology (476 citations), Molecular Biology (2.1k citations) and Pathology and Forensic Medicine (378 citations). Merja Perälä has collaborated with scholars based in Finland, United States and Norway. Frequent co-authors include Olli Kallioniemi, Suvi‐Katri Leivonen, Pekka Kohonen, Kristine Kleivi Sahlberg, Rami Mäkelä, Vidal Fey, Anne‐Lise Børresen‐Dale, Päivi Östling, Eero Vuorio and Anna Aakula. Their work appears in journals such as PLoS ONE, Cancer Research, Molecular Oncology, Oncogene and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact